WallStreetZenWallStreetZen

NASDAQ: BDTX
Black Diamond Therapeutics Inc Stock Ownership - Who owns Black Diamond Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Black Diamond Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Prakash RamanDirector2026-03-206,105$2.15
$13.13kBuy
Ali BehbahaniDirector2026-03-206,919$2.15
$14.88kBuy
Prakash RamanDirector2025-12-124,665$2.76
$12.88kBuy
Ali BehbahaniDirector2025-12-125,208$2.76
$14.37kBuy
Ali BehbahaniDirector2025-09-194,291$3.35
$14.37kBuy
Prakash RamanDirector2025-09-193,843$3.35
$12.87kBuy
Prakash RamanDirector2025-06-205,526$2.33
$12.88kBuy
Ali BehbahaniDirector2025-06-206,170$2.33
$14.38kBuy

1 of 1

BDTX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BDTX insiders and whales buy or sell their stock.

BDTX Shareholders

What type of owners hold Black Diamond Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
T Rowe Price Investment Management Inc18.51%10,606,599$27.26MInstitution
Ali Behbahani15.69%8,991,082$23.11MInsider
Versant Venture Capital VI LP7.94%4,548,481$11.69MInsider
Nea Management Company LLC7.77%4,448,757$11.43MInstitution
Growth N. V. Biotech4.77%2,733,547$7.03MInsider
Vanguard Group Inc3.82%2,188,857$5.63MInstitution
Acadian Asset Management LLC2.85%1,630,173$4.19MInstitution
Marshall Wace LLP1.94%1,110,088$2.85MInstitution
Siren LLC1.83%1,046,517$2.69MInstitution
Arrowstreet Capital Limited Partnership1.82%1,040,468$2.67MInstitution

1 of 3

BDTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BDTX65.18%34.82%Net BuyingNet Buying
KPTI20.88%79.12%Net SellingNet Selling
EDSA24.55%75.45%Net BuyingNet Buying
AGEN7.15%92.85%Net BuyingNet Buying
TNYA31.61%38.17%Net SellingNet Selling
View Top Biotech Stocks

Black Diamond Therapeutics Stock Ownership FAQ

Who owns Black Diamond Therapeutics?

Black Diamond Therapeutics (NASDAQ: BDTX) is owned by 66.00% institutional shareholders, 35.26% Black Diamond Therapeutics insiders, and 0.00% retail investors. Ali Behbahani is the largest individual Black Diamond Therapeutics shareholder, owning 8.99M shares representing 15.69% of the company. Ali Behbahani's Black Diamond Therapeutics shares are currently valued at $23.83M.

If you're new to stock investing, here's how to buy Black Diamond Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.